LIGAND PHARMACEUTICALS INC Quarterly Interest Expense in USD from Q2 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Ligand Pharmaceuticals Inc quarterly/annual Interest Expense history and growth rate from Q2 2010 to Q1 2024.
  • Ligand Pharmaceuticals Inc Interest Expense for the quarter ending March 31, 2024 was $141K, a 41.3% decline year-over-year.
  • Ligand Pharmaceuticals Inc Interest Expense for the twelve months ending March 31, 2024 was $557K, a 55.4% decline year-over-year.
  • Ligand Pharmaceuticals Inc annual Interest Expense for 2023 was $656K, a 63.5% decline from 2022.
  • Ligand Pharmaceuticals Inc annual Interest Expense for 2022 was $1.8M, a 90.8% decline from 2021.
  • Ligand Pharmaceuticals Inc annual Interest Expense for 2021 was $19.6M, a 28.4% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $557K $141K -$99K -41.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $656K $131K -$109K -45.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $765K $1K* -$331K Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.1M $284K -$154K -35.2% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $1.25M $240K -$549K -69.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $1.8M $240K -$4.23M -94.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $6.03M $332K -$4.11M -92.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $10.1M $438K -$4.45M -91% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $14.6M $789K -$5.04M -86.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $19.6M $4.47M -$1.92M -30.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $21.5M $4.44M -$1.83M -29.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $23.4M $4.88M -$1.33M -21.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $24.7M $5.83M -$2.72M -31.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $27.4M $6.39M -$2.45M -27.7% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $29.9M $6.27M -$2.72M -30.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $32.6M $6.21M -$2.8M -31.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $35.4M $8.55M -$358K -4.02% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $35.7M $8.83M -$11.3M -56.1% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $47.1M $8.99M -$2.21M -19.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $49.3M $9.01M -$4.44M -33% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $53.7M $8.91M +$5.43M +156% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $48.3M $20.1M +$16.4M +431% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-24
Q3 2018 $31.9M $11.2M +$7.81M +231% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $24.1M $13.5M +$10.1M +303% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $14M $3.48M +$539K +18.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $13.5M $3.79M +$122K +3.32% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $13.3M $3.39M +$270K +8.67% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $13.1M $3.34M +$290K +9.51% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $12.8M $2.94M -$64K -2.13% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $12.8M $3.67M Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $3.12M +$186K +6.35% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $3.05M +$82K +2.76% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $3.01M +$32K +1.08% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q3 2015 $11.8M $2.93M +$1.41M +93.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-15
Q2 2015 $10.4M $2.97M +$2.79M +1540% Apr 1, 2015 Jun 30, 2015 10-Q/A 2016-11-15
Q1 2015 $7.59M $2.97M +$2.73M +1099% Jan 1, 2015 Mar 31, 2015 10-Q/A 2016-11-15
Q4 2014 $4.86M $2.92M +$2.6M +817% Oct 1, 2014 Dec 31, 2014 10-K 2015-02-23
Q3 2014 $2.26M $1.52M +$1.12M +285% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $1.14M $181K -$272K -60% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $1.41M $248K -$664K -72.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $2.08M $318K -$408K -56.2% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-23
Q3 2013 $2.49M $394K -$341K -46.4% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-31
Q2 2013 $2.83M $453K -$309K -40.6% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $3.14M $912K +$211K +30.1% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 $2.92M $726K +$14K +1.97% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-23
Q3 2012 $2.91M $735K +$36K +5.15% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 $2.87M $762K +$88K +13.1% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-01
Q1 2012 $2.79M $701K +$278K +65.7% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 $2.51M $712K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-14
Q3 2011 $699K +$691K +8638% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 $674K +$661K +5085% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-11-14
Q1 2011 $423K Jan 1, 2011 Mar 31, 2011 10-Q/A 2012-11-14
Q3 2010 $8K Jul 1, 2010 Sep 30, 2010 10-Q/A 2012-02-10
Q2 2010 $13K Apr 1, 2010 Jun 30, 2010 10-Q/A 2012-02-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.